BioMagnetic Solutions
Private Company
Total funding raised: $2.5M
Overview
BioMagnetic Solutions is a private, revenue-generating medical device and diagnostics company specializing in ferrofluid-based cell selection technologies. Founded in 2010 and headquartered in San Diego, it targets the rapidly growing cell and gene therapy manufacturing market with cGMP-compliant products. The company is a strategic asset within the Gamma Biosciences platform, leveraging partnerships with industry leaders like Lonza to integrate its reagents into automated manufacturing systems, positioning it as a key tools provider in the advanced therapies space.
Technology Platform
cGMP-grade ferrofluid-based magnetic cell selection technology for isolating specific cell populations, comprising functionalized reagents and compatible hardware systems.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
The cell separation market is dominated by large players like Miltenyi Biotec, STEMCELL Technologies, and Thermo Fisher Scientific. BioMagnetic Solutions competes by focusing on cGMP-grade ferrofluid performance for the clinical manufacturing niche and through strategic integrations with automated platforms, rather than competing across the entire research tools landscape.